What Can Medical Device Human Factors Learn from Other Industries?

Author(s):  
L. Bryant Foster ◽  
Russell J. Branaghan ◽  
Dean Barker ◽  
Jen Donahue ◽  
Dave Mitropoulous-Rundus

Human factors has grown in popularity in the medical device industry since the introduction of FDA’s Draft Guidance Applying Human Factors and Usability Engineering to Optimize Medical Device Design in 2011. However, human factors and ergonomics has been practiced since the 1940’s and adopted by various industries, regulated and unregulated, to improve user safety and satisfaction. Over the last 70+ years, many manufacturers in industries like aerospace, aviation, automotive, and consumer goods have incorporated human factors into their product design controls. Nevertheless, many medical device manufacturers still treat human factors as a singular step (validation testing) in the regulatory submission process. Leveraging the diverse experience, we aimed to identify human factors practices that have proven successful in non-medical industries that are not commonly practiced in the medical device industry, possible reasons these practices are not used by medical device manufacturers, and recommend possible solutions. Our discussions revealed four human factors practices that are not commonly used in the medical device industry, reasons the medical device industry may be slow to adopt human factors, and potential solutions for each.

Author(s):  
Merrick F. Kossack ◽  
Andrew W. Gellatly

To meet the FDA's Quality System Regulation, medical device manufacturers must include design validation as part of their design and development activities. However, the regulation does not specify which product requirements must be validated or what methods satisfy a proper design validation process. This paper outlines an approach that device manufacturers can follow to determine which product requirements should undergo design validation testing and what types of testing methods should be used.


Author(s):  
Huiyang Li ◽  
Michael Lau

As the medical device industry establishes more rigorous human factors practices in their design and development process, this is accompanied by an increase in demand in human factors professionals. The human factors activities have been performed by both professionals with formal human factors education and training and those who come from other backgrounds, such as engineering, natural science, medical fields, design and more. Both across those disciplines and the within human factors field, there is no standard curriculum or requirements for educating and preparing human factors engineers/professionals for the medical device/health care domain. To better understand how (well) human factors professionals are prepared for the medical device industry, a survey was administered in the form of an interactive poster at the 2019 International Symposium in Human Factors and Ergonomics in Health Care. Data were collected regarding where symposium attendees, most of whom are human factors professionals in health care/medical device, learned the important knowledge/skills required for human factors practice in the medical device industry. In this paper, the method is described in details, and results from the poster survey are presented and discussed.


Author(s):  
Kyungtae Yeom ◽  
Changhyeon Song ◽  
Kwangsoo Shin ◽  
Ho Seon Choi

In the medical device industry, which is highly value-added and requires multidisciplinary knowledge, major global firms dominate the market, so it is necessary to establish a growth strategy suitable for latecomers. Through a Korean case, it was confirmed that import, diversification, and R&D activity are distinguishing strategies. The existing literature covers these strategies, but these findings are fragmented and differ from those of latecomers. This study examined the impact of the above factors on corporate growth, based on data of 440 Korean medical device manufacturers from 2011 to 2016. According to the results of panel data regression, diversification and R&D activity have a positive effect on the financial performance of a firm, while the import business model shows a negative effect. These results are expected to provide implications with respect to strategies for the growth of latecomers in the medical device industry. In future research, it is necessary to investigate how detailed strategies in accordance with the growth stages of a firm can be established.


1997 ◽  
Vol 11 (2) ◽  
pp. 116-119 ◽  
Author(s):  
Patrick J. Prendergast

The author assesses the results of the Bioengineering Design Forum – a collaboration between university researchers, clinicians and industry in Ireland. The aim of the Forum is to initiate, develop and bring to a successful conclusion R&D collaborations that lead to new or improved medical devices. By laying down certain operating procedures for the Forum, an effective ‘meeting ground’ has been developed which serves the objectives of both university engineering departments and the medical device industry in a unique way. The purpose of this paper is to relate our experiences of the Forum; they may be useful to others who would like to attempt similar initiatives in other fields. The author also describes the results that may be expected from this kind of university–industry collaboration in practice.


Sign in / Sign up

Export Citation Format

Share Document